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Commonalities and Differences in Correlates of Depressive Symptoms in
Men and Women With Heart Failure
Abstract
Objective: (i) To compare the prevalence and severity of depressive symptoms between men and women
enrolled in a large heart failure (HF) registry. (ii) To determine gender differences in predictors of depressive
symptoms from demographic, behavioral, clinical, and psychosocial factors in HF patients.
Methods: In 622 HF patients (70% male, 61 ± 13 years, 59% NYHA class III/IV), depressive symptoms were
assessed by the Patient Health Questionnaire (PHQ-9). Potential correlates were age, ethnicity, education,
marital and financial status, smoking, exercise, body mass index (BMI), HF etiology, NYHA class,
comorbidities, functional capacity, anxiety, and perceived control. To identify gender-specific correlates of
depressive symptoms, separate logistic regression models were built by gender.
Results: Correlates of depressive symptoms in men were financial status (p = 0.027), NYHA (p = 0.001);
functional capacity (p < 0.001); health perception (p = 0.043); perceived control (p = 0.002) and anxiety (p <
0.001). Correlates of depressive symptoms in women were BMI (p = 0.003); perceived control (p = 0.013)
and anxiety (p< 0.001).
Conclusions: In HF patients, lowering depressive symptoms may require gender-specific interventions
focusing on weight management in women and improving perceived functional capacity in men. Both men
and women with HF may benefit from anxiety reduction and increased control.
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Heart failure (HF) is a major cause of excess morbidity and mortality, and a leading
contributor to healthcare expenditures in the U.S. with estimated direct and indirect costs of
greater than 37.2 billion dollars per year.1 Direct costs are mainly attributed to repeat
hospitalizations (75%), and on average are approximately € 10,000 per patient per
hospitalization in Europe.2 Depressive symptoms are common in outpatients with HF with a
prevalence of 13–42%, 34–6 and the presence of depressive symptoms is linked to poorer
clinical outcomes in patients with HF 3, 7–9 Patients with HF and depressive symptoms
commonly suffer from poorer quality of life, declining functional status, greater symptom
burden, poorer adherence, more frequent rehospitalizations, and worse survival.3, 8, 10–12
Given the common finding that women experience higher levels of depression than men, 13
a major step to understanding depression in patients with HF is determining how gender
contributes to the depression experience.
Gender contributes to differences in clinical presentation and outcomes in patients with
HF, 14 yet most research on depressed patients with HF does not examine gender differences
despite the increased prevalence of depressive symptoms in women.13 Consequently, it is
impossible to determine if women and men with HF differ on important characteristics such
as demographics, behavioral, clinical, and psychosocial variables that may influence
depression. Gender differences among patients with heart failure must be considered when
developing targeted, preventive treatment strategies in order to address healthcare costs and
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societal burden related to the increasing numbers of men and women with HF.15 Therefore
the aims of this study were to 1) compare the prevalence and severity of depressive
symptoms between men and women enrolled in a large HF registry and 2) to determine
gender differences in predictors of depressive symptoms from among relevant demographic
(i.e., age, ethnicity, marital status, education, and financial status), behavioral (i.e., smoking
and exercise), clinical (i.e., HF etiology, functional status, functional capacity, comorbidity
burden, and body mass index), and psychosocial (i.e., anxiety, perceived control, and health
perceptions) factors.
REVIEW OF RELEVANT LITERATURE
Heart failure (HF) patients with depressive symptoms have poorer clinical
outcomes, 3, 7, 8, 10, 11, 16–19 lower quality of life and substantially higher health care costs
than HF patients without such symptoms.3, 8, 11, 12 A recent meta analysis demonstrated that
patients with HF who have depressive symptoms are more than twice as likely to die or
experience a cardiac event compared to HF patients without depressive symptoms.3
Although depression is more prevalent in women overall and in cardiac disease in general,20
investigators recently reported finding more male than female depression sufferers in a large
cohort of patients with HF.21 However, little is known about the role of gender in comorbid
HF and depression. Given the importance of depression in HF, further investigation is
needed to ascertain how gender interacts with HF and depressive symptoms to influence
clinical outcomes.
Previous studies have reported demographic factors which are related to HF and depression.
The incidence of depression is inversely related to age.22 Patients with HF manifest greater
depressive symptoms when they are younger.7, 8, 23, 24 Other sociodemographic risk factors
for depression among patients with HF include low educational attainment, being unmarried
or living alone, and being unemployed or having a low income.17, 25–27 In comorbid
depression and HF, ethnicity prevalence data have been mixed, with one large study
reporting a higher rate of depression history in whites16 and a smaller study finding that
non-Hispanic Blacks were more likely to be depressed than others.28
Biological and behavioral factors are likely linked to both depression and HF. For example,
higher NYHA functional class is associated with higher prevalence of depression3 and may
be a reflection of higher illness burden from HF that contributes to depression.15 Unhealthy
behaviors such as alcohol and tobacco use, poor nutrition, sedentary lifestyle and poor
adherence to medical regimens are associated with depression in HF patients.29, 30
Patients with chronic illnesses such as HF experience increased mental distress.31, 32
Symptoms of anxiety are highly prevalent in HF patients. 28, 33, 34 Anxiety symptoms
overlap significantly with depressive symptoms and increase the risk of mortality and
functional disability as well as health care utilization and cost.8, 35, 36 In addition to anxiety,
perceptions of health status, functional capacity, and perceived control influence the
incidence and severity of depressive symptoms37–39 and are linked to poorer outcomes.4041
Higher levels of perceived control are linked with fewer anxious and depressive symptoms
and a higher likelihood of patient involvement in self-care management, which is related to
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improved outcomes in HF patients.28, 38, 42 HF patients who indicate low perceived health
status are more prone to develop depressive symptoms.17
Previous studies of depression and HF have included measures of sociodemographic,
clinical, behavioral and psychosocial risk factors.7, 17, 29, 43–45 A comprehensive
multivariate examination has not, however, been conducted and few studies have reported
comparisons by gender.7, 10
METHODS
Data from the HF Quality of Life Collaborative,46–48 an ongoing HF health-related quality
of life registry, were used to meet the study aims. A total of 622 patients in the registry had
complete data on all variables.
Adult patients over age 18 were enrolled from cardiology clinics associated with academic
medical centers in the Midwest, Northeast, South and Southeast of the United States.
Patients were included if they had a documented diagnosis from a cardiologist of chronic HF
from either preserved or non-preserved ejection fraction and were community dwelling (i.e.,
not residing in an extended care or skilled nursing facility). Patients were excluded if they
had acute myocardial infarction or stroke within the prior 3 months or were cognitively
impaired as determined by inability to answer questions from the researcher, complete
questionnaires, or provide informed consent. All participants provided written informed
consent, and all participating sites obtained institutional review board approval.
Measures
Demographic variables—Data on age, gender, ethnicity, education level, marital status,
and financial status were collected by patient self-reported questionnaires. Because
participants commonly are reluctant to provide income data, we used an accepted alternative
approach in which patients were asked to respond to the question, “Considering your
household income, would you say you…” with the following three options: 1) are
comfortable; 2) have enough to make ends meet; or 3) do not have enough to make ends
meet?” This method reflects the impact of a participant’s socioeconomic status on daily
life.49
Behavioral and clinical variables—Data on smoking and exercise were collected using
patient questionnaires. Body mass index (BMI) was calculated from height and weight
available by medical record review. Etiology of HF was determined from medical record
review, and was indicated as ischemic or non-ischemic (includes largely idiopathic and
hypertensive HF).
NYHA functional class was determined by careful patient interview. NYHA is a subjective
indicator of functional status. 50 Based on patients’ report of how able they are to perform
their usual activities they are assigned a NYHA classification of I (ordinary physical activity
causes no symptoms of fatigue, dyspnea, angina or palpitations), II (symptoms with ordinary
physical activity that slightly limit physical activity), III (symptoms occur with less than
ordinary physical activity and markedly limit activity) or IV (symptoms occur even at rest).
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Reproducibility both among different raters (inter-rater reliability) and across the same rater
(intra-rater reliability) was insured by training raters and testing them in sample patients
until inter-rater agreement is 100%.
Comorbidity burden was assessed using the interview format of the Charlson Comorbidity
Index.51 Higher scores on the Charlson Comorbidity Index indicate greater comorbidity
burden. Most conditions are scored with 1 point although some (e.g., hemiplegia, cirrhosis)
are assigned >1 point. Scores can range from 0 to 34 but because each subject has HF they
will have a score >1. Responses are summed, weighted, and indexed into one of 3 categories
(low, moderate, or high) according to the published method. Validity was demonstrated
when comorbidity category predicted mortality, complications, health care resource use,
length of hospital stay, and discharge disposition.52, 53 Comorbidities were documented
during the patient and family interview at the time of patient enrollment, and confirmed by
reviewing the medical record.
The Duke Activity Status Index (DASI) was used to measure self-reported functional
capacity with higher scores indicating higher functional capacity.54 The DASI consists of 12
activity items. Each item has four (1-can do without limitation to 4 – unable to do) response
options. Each item is scored with a zero given to responses of 2, 3, or 4 all of which indicate
there is some degree of limitation performing the activity. For a response of 1 (can do
without difficulty), the item is given a weighted score based on the MET level associated
with the given activity. The total score is calculated by summing all the item scores, and can
range from 0 to 58.2. The reliability55 and the validity55, 56 of the DASI have been
supported in previous studies. The Cronbach’s α for this scale in the current study was 0.85.
Psychosocial variables—The severity of depressive symptoms was measured using the
Patient Health Questionnaire-9 (PHQ-9).57, 58 The PHQ-9 is widely used and has been
demonstrated to be valid across diverse groups of individuals including patients with HF.59
The items on the PHQ-9 are derived from DSM-IV criteria for diagnosing depression.60
This instrument consists of 9 items each rated by the patient using the range of 0 (not at all)
to 3 (nearly every day). The scores range from 0–27 with higher scores indicating more
severe depressive symptoms. A score of greater than or equal to 10 is defined as having
moderate depressive symptoms, 57, 58 and this is the cutpoint we used in this study to define
the presence of depressive symptoms.
Anxiety: Anxiety was measured using the anxiety scale of the Brief Symptom Inventory
(BSI).61, 62 The anxiety scale of the BSI consists of six items that are rated by patients on a
5-point Likert type scale that ranges from 0 (no distress related to the item) to 4 (extreme
distress related to the item). The score is calculated by averaging the ratings of the items
with a possible range from 0 to 4. Acceptable reliability and validity have been
demonstrated for this instrument in psychiatric and medical patients, including those with
HF.61–63
Perceived Control: Perceived control was measured by the Control Attitudes Scale
(CAS).64 The CAS consists of a total of 4-items that are ranked by the respondent on a 7-
point scale according to the degree to which they agree or disagree with a given statement;
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ratings on two of the items are reversed before scoring. The total score can range from 4 to
28 with higher scores indicating greater perceived control. The instrument has well-
established reliability and validity in a variety of cardiac populations, including HF.38, 65
Health Perception: Health perception was measured by a single item from the Medical
Outcomes Study Short Form −36. Patients rated their health on a Likert type scale 1–5, (1
equals excellent, and 5 equals poor).
Data Analysis
To describe sample characteristics, we compared each demographic, behavioral, clinical and
psychosocial characteristic based on gender and presence of depressive symptoms.
Comparisons were done using two-way analysis of variance (ANOVA), or chi-square, as
appropriate. For ANOVAs, posthoc group comparisons were conducted using the Tukey
statistic.
To address Specific Aim 1, chi-square was used to determine the prevalence of depressive
symptoms in men and women by comparing the proportion of men and women who met
criteria for depressive symptoms. Independent t-tests were used to determine the severity of
depressive symptoms in men and women by comparing the means of scores on the PHQ-9
between men and women. Analysis of variance (ANOVA) was used to determine main
effects of gender and/or depressive symptoms.
To address Specific Aim 2, regression analyses were used to identify multivariate predictors
of depressive symptoms in men and women. Separate multiple regressions were run for men
and women. Variables were entered in three blocks: demographic, behavioral and clinical,
and psychosocial variables to determine which factors were independently associated with
depression scores. At each step, variables were forced into the model in order to provide
simultaneous control within the step.
RESULTS
Sample Characteristics
Data from a total of 622 patients, 436 men and 186 women, are included.
Sample characteristics are compared among patients with and without depressive symptoms
stratified by gender in Table 1. Interactions were examined first, and if no interaction was
present, main effects were examined. There were no main effects for gender or depressive
symptoms in the characteristics of ethnicity, marital status, smoking history, or body mass
index. The only interaction in gender by depressive symptoms was present for the variable
of financial status. Women who reported not having enough to make ends meet were more
likely to have higher levels of depressive symptoms than women who reported being
financially comfortable or having enough to make ends meet. There was no association
between levels of depressive symptoms and financial status in men.
There were differences based on depressive symptoms (i.e., main effect of depressive
symptoms) in age, years of education, exercise behavior, NYHA class, comorbidity burden,
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health perceptions, anxiety and perceived control (Table 1). With regard to age, both men
and women with depressive symptoms were younger compared to those without depressive
symptoms (Table 1, p = 0.02 main effect for depressive symptoms). Regardless of gender,
those with depressive symptoms had attained fewer years of education than those without
depressive symptoms (p = 0.015, Table 1). In both men (p = 0.001) and women (p = 0.015),
those with depressive symptoms reported performing less exercise than those without
depressive symptoms (Table 1). In both men and women (p = 0.001 for both), there was a
greater proportion of people with depressive symptoms in the worse NYHA functional
classes (Table 1). Regardless of gender, those who had depressive symptoms reported a
greater comorbidity burden (p = 0.001) than those who did not have depressive symptoms
(Table 1). In both men and women, health perceptions were worse (p = 0.001), anxiety
levels were higher (p = 0.001), and levels of perceived control were lower (p = 0.001) in
those with depressive symptoms than in those without depressive symptoms (Table 1).
There were gender differences (i.e., main effect of gender), but no difference based on
depressive symptoms in etiology of heart failure (Table 1). More women than men had a
non-ischemic etiology (hypertension) for their HF (p = 0.05).
There was both a main effect of gender (p = 0.045) and a main effect of depressive
symptoms (p = 0.001) on functional capacity as measured by the DASI (Table 1). Women
reported lower functional capacity than men. Individuals of either gender who had
depressive symptoms reported lower functional capacity than those without depressive
symptoms.
Specific Aim 1
A total of 134 men (28%) met the criterion for depressive symptoms, while 65 women
(35%) met the criteria for depressive symptoms (p = 0.00). Mean scores on the PHQ-9 were
significantly different between men and women (7.02 ± 6.0 versus 8.63 ± 6.3, respectively,
p = 0.003), with women having higher mean scores on the PHQ-9, representing greater
severity of depressive symptoms than men
Specific Aim 2: Gender-Specific Predictors of Depression
Separate multivariate regression analyses were used to identify predictors of depressive
symptoms in men (Table 2) and women (Table 3). In men, demographic variables entered in
the first step explained 7% of the variance in depressive symptoms. The R2 increased to
29% in the second step with the addition of the behavioral and clinical variables. The R2
increased by an additional 19% in the third step with the addition of the psychosocial
variables. The final model explained 49% of the variance in depressive symptoms in men.
Six variables independently predicted higher levels of depressive symptoms in men: lower
financial status, worse NYHA class, poorer functional status, poor ratings of perceived
health, increased anxiety and low perceived control.
In women, demographic variables entered in the first step of the regression model explained
12% variance in depressive symptoms. The R2 increased by 17% to 27% in the second step
with the addition of the behavioral and clinical variables. The R2 increased by an additional
25% in the third step with the addition of the psychosocial variables. The final model
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explained 52% of the variance in depressive symptoms in women. Three variables
independently contributed to the prediction of higher levels of depressive symptoms in
women: higher BMI, higher anxiety and lower perceived control.
DISCUSSION
The present study is among the first to report differences in behavioral and clinical
correlates of depressive symptoms and report commonalities of psychosocial correlates of
depressive symptoms in a diverse multicenter outpatient sample of women and men. In the
current study, depressive symptoms were predicted by socioeconomic status, NYHA
Classification, functional status, current health perception, perceived control and anxiety in
men. In women, predictors of depressive symptoms were BMI, perceived control and
anxiety. Only perceived control and anxiety were predictors in both men and women. In HF
patients their perceptions of their ability to control their symptoms, illness and lives was an
important correlate of depressive symptoms. A sense of control is known to be important in
reducing anxiety and depression. This relationship has also been found to be true in many
cohorts of cardiac patients. In randomized trials, where HF patients have been given control
of therapeutic strategies such as home-based exercise programs, daily weights and self-
management, investigators have shown favorable effects on QOL. The finding that
perceived control is an important correlate of depressive symptoms has implications for the
development of more nursing interventions. Reducing morbidity and mortality in HF
patients with depressive symptoms should be the goal for optimal outcomes and perhaps
men and women need different standards of care. HF patients require a high degree of self-
management thus programs focused on increasing autonomy and encouraging patient
control in decision making regarding care should be designed. We determined that women
with HF reported substantially higher levels of depressive symptoms than men. Few studies
of HF patients report significant gender differences in depression. Friedman reports no
gender differences in depression among older adults with HF. 66 When comparing men and
women Heo et al found high levels of depression and anxiety, but no significant gender
differences.67, 68 Vaccarino found a trend toward greater depressive symptoms in women. 19
Sample sizes in the previous studies were relatively small, ranging from 98 to 381,19, 66–68
and it may be that the small sample sizes in prior research contribute to the lack of gender
differences. This speculation is suggested by the findings from a large study of over 48,000
hospitalized HF patients in which women and whites were more likely to have a history of
depression when compared with men and minority groups.16
In conducting separate multivariable models for each gender, we demonstrated that there are
different models of factors associated with the presence of depressive symptoms in women
and men with HF. In both men and women with HF, models that included demographic,
clinical, behavioral and psychosocial variables explained about half the variance in
depressive symptoms. In both men and women, the addition of psychosocial variables
explained the largest amount of variance in depressive symptoms. The strong predictive
value of psychosocial variables over clinical and demographic variables has been
demonstrated previously.64, 69 Only perceived control and anxiety were correlates in both
men and women. In women, the relationship of anxiety and perceived control to depressive
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symptoms was more powerful than similar relationships in men, with depressive symptoms
explaining greater than 50% of the model variance in women.
For both men and women with HF, their perceptions of their ability to control their
symptoms, illness and lives was an important correlate of depressive symptoms. A sense of
control is known to be important in reducing anxiety and depression in patients experiencing
cardiac events.70, 71 This relationship has also been found to be true in many cohorts of
cardiac patients, including those recovering from myocardial infarction and coronary artery
bypass graft surgery. 64, 72 In randomized trials, where HF patients have been given control
of therapeutic strategies such as home-based exercise programs, daily weights and self-
management of diuretic therapy, investigators have demonstrated improved outcomes.38, 73
The finding that perceived control is an important correlate of depressive symptoms has
implications for the development of more nursing interventions.
For both men and women in the current study, anxiety was a correlate of depressive
symptoms. Anxiety, along with other negative emotions, is known to be predictive of
CHD 74 and stroke.75 Researchers have reported that both men and women who struggle
with the emotional and life-altering effects of HF have heightened levels of anxiety. 42
Further, anxiety is highly prevalent in HF patients, with reports as high as 63%, similar to
rates in lung disease or cancer. 76 Of note, anxiety at any level in the HF population has
negative consequences.33, 34 The current study confirms the strong association of anxiety
and depressive symptoms in both men and women. While an initial study indicated that a
stress-management intervention may reduce depressive symptoms, along with other negative
physical and emotional symptoms, in HF patients,77 future studies may need to identify
gender-specific interventions to reduce anxiety in men and women with HF in order to
positively affect comorbid depression.
In men, depressive symptoms were associated with financial status, functional status
(NYHA classification), functional capacity (DASI scores), current health perception,
perceived control and anxiety. The NYHA classification provides a measurement of
perceptions of disease - related restrictions in physical activity.78 In this study, NYHA
classification contributed independently to the presence of depressive symptoms for men,
but not for women with HF. Physical restrictions that affect daily activities have been
reported as more bothersome for males which may affect their perception of self-worth.79
Additionally, it is known that MI patients who have depressive symptoms are less likely to
exercise.80 Further, the relationship between depressive symptoms is believed to be
bidirectional, so that both contribute synergistically to a downward spiral characterized by
Whooley et al as a “mutually reinforcing” phenomena.80 It is possible that this “mutually
reinforcing” relationship of depressive symptoms and lack of exercise is mediated by other
factors, such as increased negative health perceptions and lower levels of perceived control
over health, among non-exercisers. Further study is needed to elucidate these relationships
in the context of HF and inform targeted interventions aimed at reducing depressive
symptoms and increasing exercise in HF patients.
Health perception was a significant predictor of depressive symptoms for men only. A
possible explanation for this male-only finding may be that men may place more value than
Eastwood et al. Page 8
Eur J Cardiovasc Nurs. Author manuscript; available in PMC 2014 May 08.
women on role-related self-worth. They describe the physical limitations, social restrictions
in their work and leisure activities caused by HF as hindering them from taking part in
activities that had been a natural part of their lives.81 For men recovering from MI, in
particular, functional status appears to have great importance and has been shown to have
significant impact on self rating of health.82 Faced with HF symptoms, men with HF may
perceive their health as unrealistically low, underestimate their actual functional potential,
and believe that they have lost core social roles as providers. Such negative thinking would
be consistent with depressive symptoms.7 While further study to support our findings is
needed, interventions for men with HF that are designed to focus on attaining realistic
perceptions of health warrant exploration.
Body mass index was a correlate of depressive symptoms in women with HF only. Weight
is an important issue in women that can transcend their feelings about body image and
societal expectations.83 Being overweight or obese may potentially increase feelings of
anxiety and low perceived control in women in this study. Primary care providers need to
address BMI and develop individualized strategies for weight reduction and management to
deter the escalating and detrimental effects of high BMI on depressive symptoms in women.
Future studies should include exercise, nutrition and psychological interventions to reduce
the incidence and progression of depressive symptoms in women and be longitudinal in
design.
Implications for Nursing
Reducing hospital readmissions, morbidity and mortality in HF patients with depressive
symptoms should be the goal for optimal outcomes and perhaps men and women need
different standards of care.79 Advanced Practice Nurses (APNs), who possess advanced
assessment and disease management skills, are in a unique position to assess and evaluate
depressive symptoms in HF patients and to employ educational and counseling programs to
reduce depressive symptoms in HF patients. Documentation of mental health screening is
essential in HF patients in order for eligible patients to receive necessary mental health
treatment.84 APNs are adept at pulling care teams together to institute patient –centered
care, promoting care integration and coordination, and improving access to care. Such
activities hold great potential to identify and treat depressive symptoms in men and women
with HF. HF patients require a high degree of self-management thus programs focused on
increasing autonomy and encouraging patient control in decision making regarding care
should be designed. Educating patients and families to identify worsening symptoms and to
adjust and revise treatments is an example of increasing control and potentially decreasing
hospitalizations and economic burdens on the family and on society.
Previous studies have found little gender difference in predictors of symptoms of
depression.66, 85 Important findings from the present study should be used to develop
different management models for men and women. Nursing will play a critical role in
adequately identifying and managing HF patients at risk for depression, and decreasing the
personal and societal burden of depression in this growing population.
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Strengths and Limitations—The strengths of our investigation included a relatively
large sample size, multicenter enrollment of subjects, and the availability of a broad
spectrum of covariates of interest for multivariable analyses by gender. In most previous
studies interpretation of the findings on gender differences has been seriously hampered due
to power problems. In addition the number of variables was restricted and inconsistent
across designs. Limitations of the current study include a use of a convenience sample,
which limits the generalizability. Patients who have depressive symptoms may be less likely
to participate in research. Data for the study were collected by self-report questionnaires that
may not reflect patients’ true feelings. The sample was predominately Caucasian and
English-speaking, so caution should be used in generalizing results to those patients who do
not speak English and are not Caucasian.
Conclusions
Heart failure is a debilitating and chronic clinical syndrome which is compromised by the
presence of depressive symptoms. Studies of correlates of depressive symptoms among
patients with HF are important because symptomatic depression is a widespread and
debilitating illness. The present study demonstrates that there are differences and
commonalities in correlates of depressive symptoms in men and women from a relatively
large, heterogeneous sample of patients with HF from diverse parts of the country.
We found distinct differences in demographic, clinical, behavioral and psychosocial
predictors of symptoms of depression for men and women. Identification of correlates of
depressive symptoms and of gender differences is helpful for the development of gender-
based risk profiles, and determination of targets of gender-based interventions to reduce
depressive symptoms. In the present study the psychological factors of perceived control and
anxiety were independent correlates of depressive symptoms in both men and women.
Although anxiety and perceived control were also strong correlates of depressive symptoms
for women with HF, they seemed to stem from important relationships rather than physical
achievement. Evidence from this study provides justification to support gender specific
standards of care 79 and gender specifics treatments and management to address the problem
of depressive symptoms, which have been associated with increased use of health care
resources and increased costs.7
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Table 2
Predictors of depressive symptoms in men (N= 436)
Predictor variables Standardized β* p-value*
 Age −0.003 0.937
 Ethnicity 0.026 0.485
 Marital status −0.013 0.731
 Education −0.022 0.546
 Financial status 0.087 0.027
 Exercise −0.065 0.074
 Smoking −0.014 0.709
 Body mass index −0.019 0.603
 Charlson Comorbidity Index scores 0.017 0.665
 Etiology 0.075 0.061
 NYHA class 0.138 0.001
 Functional capacity (DASI) −0.159 <0.001
 Health perception 0.086 0.043
 Perceived control −0.120 0.002
 Anxiety 0.423 <0.001
Notes: NYHA= New York Heart Association; DASI Duke Activity Status Index;
*Standardized βs and p-values shown are for the final model
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